Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
Heat shock protein 27 in multiple sclerosis relapses.
Synthesis of 5α-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: Discovery of a novel neuroinflammation inhibitor.
Immunology: A tolerant approach.
Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.
Prediction of response to interferon therapy in multiple sclerosis.
Is natalizumab overshooting its rebound?
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
Multiple Sclerosis and Venous Abnormalities: Medicine in the Age of Social Media.
Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Stem cell therapy for white matter disorders: don't forget the microenvironment!
Secukinumab shines in small MS trial
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.

Pages